Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity

Journal of Virology

Volumn 75, Issue 4, 2001, Pages 1834-1841

  Shehu Xhilaga, M ^a   Crowe, S M ^a   Mak, J ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARTICLE; DIMERIZATION; ENZYME ACTIVITY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; RIBOSOMAL FRAMESHIFTING; RNA PROCESSING; STRUCTURAL GENE; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS INFECTIVITY;

CELL LINE; DIMERIZATION; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, GAG; HIV-1; HUMANS; RNA, VIRAL; TRANSFECTION; VIRAL PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 0035138477     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.4.1834-1841.2001     Document Type: Article

References (46)

1. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation
2. Role of the DIS hairpin in replication of human immunodeficiency virus type 1
3. RNA packaging
4. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans
5. Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro
6. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1
7. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing
8. Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: Requirements for expression of the gag-pol fusion protein
9. Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA
10. Suppression of UAA and UGA termination codons in mutant murine leukemia viruses
11. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions
12. Maturation of dimeric viral RNA of Moloney murine leukemia virus
13. Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase
14. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev
15. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1
16. Lys3 into HIV-1
17. Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region
18. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
19. Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins
20. Expression of the Rous sarcoma virus Pol gene by ribosomal frameshifting
21. Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines
22. Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles
23. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor
24. Murine leukemia virus mutation: Protease region required for conversion from "immature" to "mature" core form and for virus infectivity
25. Trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1
26. A 19-nucleotide sequence upstream of the 5′ major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA
27. Mechanisms of translational suppression used in the biosynthesis of reverse transcriptase
28. Foamy viruses are unconventional retroviruses
29. Lys into human immunodeficiency virus type 1 particles
30. gag-pol incorporation into HIV-1
31. Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site
32. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells
33. Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication
34. Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA
35. RNA dimerization defect in a Rous sarcoma virus matrix mutant
36. gag and is incorporated into viruslike particles
37. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production
38. Cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA
39. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization
40. gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles
41. Retroviral gene expression. II. Synthesis, processing, and assembly of viral proteins
42. Functional role of human immunodeficiency virus type 1 Vpu
43. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus
44. Form, function, and use of retroviral Gag proteins
45. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein